Healthcare -
Biotechnology - NASDAQ - US
$ 13.7
1.48 %
$ 623 M
Market Cap
-13.43
P/E
CAPR - STOCK-BASED COMPENSATION
Stock-based Compensation CAPR - Capricor Therapeutics, Inc.
7.39 M
LAST VALUE
57.88%
2 YEAR CAGR
33.77%
5 YEAR CAGR
39.57%
10 YEAR CAGR